Condition: Edema Secondary · Edema Leg · Sponsor: Jemincare
To Evaluate the Safety, Efficacy, and Pharmacokinetic Characteristics of JMKX003142 Administered Randomly, Open-label, Active-controlled Study in Chinese Renal Edema Patients.
This description comes directly from the study's public registry record.
Lin Shi · +8617710157616 · shilin2@jemincare.com
Always discuss trial participation with your own doctor first.
| Fudan University Affiliated Zhongshan Hospital | Shanghai, China | Recruiting |
| Zhejiang Hangyu Pharmaceutical Co., Ltd（subsidiary of Jemincare） | Shanghai, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06670534